Woodline Partners LP Gh Research PLC Transaction History

Woodline Partners LP

  • $9.97 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$14.1 - $27.9 $689,010 - $1.36 Million
-48,866 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$16.51 - $23.68 $1.49 Million - $2.13 Million
-90,031 Reduced 64.82%
48,866 $1.08 Million
Q2 2021

Aug 16, 2021
BUY
$19.25 - $21.73 $2.67 Million - $3.02 Million
138,897 New
138,897 $3.02 Million

Others Institutions Holding GHRS

# of Institutions
34
Shares Held
23.5M
Call Options Held
63.1K
Put Options Held
1.9K
View Full List

About GH Research PLC

GHRS Quotes by TradingView
  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $333M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email